Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
91 /100
CRITICAL RISK
Score updated Sep 12, 2026

PPCB — Propanc Biopharma, Inc. Dilution Risk Tracker

Track PPCB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PPCB — Get alerts when the score changes →

As of September 12, 2026, Propanc Biopharma, Inc. (PPCB) has a DilutionWatch DilutionScore of 91/100, rated CRITICAL dilution risk. Propanc Biopharma, Inc. has a market capitalization of $4.15M, 56.96M shares outstanding, 7 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $4.00M, ATM program capacity of $7.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
95
📊 Float Risk
92
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

🌩️
Severe
Multiple high-probability dilution events detected
model est. 54%
💰 Capital Raise model 93%
• Critical: only 0.4 months cash remaining
• Active shelf registration ($4M, 96% of market cap)
🔄 Reverse Split model est. 15%
• Only 0 months cash — financial pressure
📉 Score Deterioration model 15%
• Score already CRITICAL (91/100) — events likely imminent
🔔 Track PPCB — Get forecast alerts →

Market Data

Market Cap$4.15M
Shares Outstanding56.96M
Float1.63M
Cash$93.2K
Debt$1.01M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore91/100DilutionWatch score record
Shares Outstanding56.96MVerified float table or market cache
Public Float1.63MVerified float table or market cache
Market Cap$4.15MMarket data cache
Cash Runway0.4 monthsDilutionWatch score inputs
Shelf Capacity$4.00MSEC-derived dilution fields
ATM Capacity$7.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 424B3 1, EFFECT 3, S-1 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 258.8% shares (2026Q1 vs prior)
7 institutional holders · 462.4K shares
#1 UBS Group AG 182.6K shares
#2 JANE STREET GROUP, LLC 143.2K shares
#3 Marex Group plc 67.7K shares
+ 4 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest336.0K
Days to Cover1.0
% of Float20.6%
FINRA data as of Aug 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-06-30
EFFECT EFFECT 2026-07-27
EFFECT EFFECT 2026-04-20
S-1 SHELF 2026-04-10
424B3 ATM 2026-03-06
Full SEC filing analysis available with free account

Recent News

Factual PPCB Dilution Snapshot

Propanc Biopharma, Inc. (PPCB) has a DilutionScore of 91/100, rated Critical dilution risk. Score date: September 12, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PPCB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PPCB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,348+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PPCB
PPCB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.